BioSpace News Archive

Arix Bioscience plc Co-leads $58 million Series A investment round for VelosBio

Arix co-leads a $58 million Series A investment in new Group Business, VelosBio Inc., bringing core portfolio1 to 15 companies

October 3, 2018
·
5 min read
Business

LGC invests in new GMP analytical capability

LGC Axolabs announces a significant investment at its site at Kulmbach, Germany, to expand the capacity of its specialist therapeutic oligonucleotide development solutions business and create a new GMP analytical capability.

October 3, 2018
·
2 min read
Business

TxCell terminates its OCABSA financing program following closing of the acquisition by Sangamo of a majority stake in TxCell

TxCell SA today announces that the actions provided for by the agreement entered into between TxCell and Yorkville in July 2018

October 3, 2018
·
5 min read
OncoDNA included in Spanish medical oncology guidelines for diagnosis cancers of unknown primary origin

Type of genomic tumor analysis demonstrated by OncoDNA in study now included in the general guidelines for the diagnosis of cancers of unknown primary origin in Spain

October 3, 2018
·
4 min read
FDA

Eisai’s Fycompa Newly Approved by U.S. FDA as Treatment for Partial-Onset Seizures in Pediatric Patients with Epilepsy

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai’s antiepileptic drug (AED) Fycompa (perampanel)

October 3, 2018
·
7 min read
BioMidwest

Empirical Bioscience’s New EB Pure Plasmid Mini-Prep Kit Offers High-Quality DNA in 30 Minutes or Less

Empirical Bioscience announced the introduction of a new EB Pure Plasmid Mini-Prep Kit today.

October 3, 2018
·
1 min read
Deals

Allogene Therapeutics Eyes IPO of up to $288 Million

Six months after officially launching and one month after securing $120 million in private financing, Allogene Therapeutics is looking to score between $272 and $288 million from an initial public offering.

October 3, 2018
·
2 min read
·
Alex Keown
Genetown

TESARO Announces Data Presentations at the SITC 2018 Annual Meeting

TESARO, Inc. today announced that data from a total of five abstracts will be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting from November 7-11, 2018 in Washington, D.C.

October 3, 2018
·
3 min read
AusCann Releases Cannabinoid Medical Education Resources

AusCann releases online education courses as part of its Medical Outreach Program to support Australian health professionals make informed decisions regarding cannabinoid therapeutics.

October 3, 2018
·
1 min read
Drug Development

Bionomics Announces that BNC210 Doesn’t Treat PTSD Symptoms

Yesterday, top-line data from Bionomics Limited revealed details of the biopharmaceutical company’s Phase II clinical trial of BNC210 in regards to patients with post traumatic stress disorder.

October 3, 2018
·
3 min read
·
Elizabeth Glasure